These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32767034)

  • 1. Assessment of Dose Proportionality of Rivaroxaban Nanocrystals.
    Demir H; Gulsun T; Ozkan MH; Nemutlu E; Sahin S; Öner L
    AAPS PharmSciTech; 2020 Aug; 21(6):228. PubMed ID: 32767034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
    Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
    Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel rivaroxaban-loaded poly(lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent anticoagulant activity and toxicological profile.
    Machado ME; de Souza Furtado P; da Costa Bernardes Araújo C; Simon A; de Moraes MC; Rodrigues Pereira da Silva LC; do Carmo FA; Cabral LM; Sathler PC
    Nanotechnology; 2021 Mar; 32(13):135101. PubMed ID: 33276347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect.
    Anwer MK; Mohammad M; Iqbal M; Ansari MN; Ezzeldin E; Fatima F; Alshahrani SM; Aldawsari MF; Alalaiwe A; Alzahrani AA; Aldayel AM
    J Thromb Thrombolysis; 2020 Apr; 49(3):404-412. PubMed ID: 31898270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Development and Optimization of Hot-Melt Extruded Amorphous Solid Dispersions Containing Rivaroxaban in Combination with Polymers.
    Lee JH; Jeong HS; Jeong JW; Koo TS; Kim DK; Cho YH; Lee GW
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33800741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube.
    Moore KT; Krook MA; Vaidyanathan S; Sarich TC; Damaraju CV; Fields LE
    Clin Pharmacol Drug Dev; 2014 Jul; 3(4):321-7. PubMed ID: 27128839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan caged liposomes for improving oral bioavailability of rivaroxaban:
    Elsayad MK; Mowafy HA; Zaky AA; Samy AM
    Pharm Dev Technol; 2021 Mar; 26(3):316-327. PubMed ID: 33356742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign.
    Alshora DH; Ibrahim MA; Elzayat E; Almeanazel OT; Alanazi F
    PLoS One; 2018; 13(7):e0200218. PubMed ID: 29985967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
    Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
    Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Optimization of Rivaroxaban by Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Enhanced Oral Bioavailability and No Food Effect.
    Xue X; Cao M; Ren L; Qian Y; Chen G
    AAPS PharmSciTech; 2018 May; 19(4):1847-1859. PubMed ID: 29637496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
    Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
    Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K
    Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and pharmacokinetics of cyadox nanosuspension.
    Sattar A; Chen D; Jiang L; Pan Y; Tao Y; Huang L; Liu Z; Xie S; Yuan Z
    Sci Rep; 2017 May; 7(1):2289. PubMed ID: 28536446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis.
    Dias C; Moore KT; Murphy J; Ariyawansa J; Smith W; Mills RM; Weir MR
    Am J Nephrol; 2016; 43(4):229-36. PubMed ID: 27100875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
    Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
    Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies.
    Zhang L; Peters G; Haskell L; Patel P; Nandy P; Moore KT
    J Clin Pharmacol; 2017 Dec; 57(12):1607-1615. PubMed ID: 28679020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of loratadine nanocrystal tablets to improve the solubility and dissolution for enhanced oral bioavailability.
    Li J; Zhou Y; Aisha M; Wu J; Wang H; Huang F; Sun M
    J Pharm Pharmacol; 2021 Jun; 73(7):937-946. PubMed ID: 33963858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.